NanoTag Biotechnologies

NanoTag Biotechnologies mainly focuses on the development, production, and application of single-domain antibodies (sdAbs). The company leverages its expertise in biotechnology to mass-produce these specialized antibodies using recombinant cell cultures, thereby minimizing animal use. Its core business includes the discovery and validation of sdAbs, aiming to support research, diagnostic, and therapeutic applications.